Evidence map›Paper›PMID 32642819›Full record

ArticlePharmaceutical research2020

Dual-pH Sensitive Charge-Reversal Drug Delivery System for Highly Precise and Penetrative Chemotherapy.

Weiguo Chen, Ji Li, Yan Xing, Xiaowei Wang, Hongyan Zhang, Mingyu Xia, Dongkai Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Weiguo ChenDepartment of Traditional Chinese Medicine, Shenyang Pharmaceutical University, No.103, Wenhua Road, Shenyang, 110016, China.
Ji LiDepartment of Traditional Chinese Medicine, Shenyang Pharmaceutical University, No.103, Wenhua Road, Shenyang, 110016, China.
Yan XingDepartment of Pharmacology, Shenyang Pharmaceutical University, No.103, Wenhua Road, Shenyang, 110016, China.
Xiaowei WangDepartment of Pharmaceutics, Shenyang Pharmaceutical University, No.103, Wenhua Road, Shenyang, 110016, China.
Hongyan ZhangDepartment of Pharmaceutics, Shenyang Pharmaceutical University, No.103, Wenhua Road, Shenyang, 110016, China.
Mingyu XiaDepartment of Pharmacology, Shenyang Pharmaceutical University, No.103, Wenhua Road, Shenyang, 110016, China. xmywd@vip.sina.com.
Dongkai WangDepartment of Pharmaceutics, Shenyang Pharmaceutical University, No.103, Wenhua Road, Shenyang, 110016, China. wangycsyphu@126.com.ORCID http://orcid.org/0000-0002-4081-8443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe complex physiological barriers impose extremely conflicting demands on systemic drug delivery, so both particle size and surface charge of the nanoplatforms become vital factors. As a carbon-based nanomaterial with excellent optical properties, carbon dots are not suitable for direct systemic transport in vivo, which limits their application in the field of biomedical imaging, especially in the areas of diagnosis and cancer treatment. Liposomes have been developed as universal nanocarriers for various drugs. In this study, we aimed to build a highly precise and penetrative drug delivery system (DDS) using carbon dots encapsulated by liposomes.

methodsCarbon dots (CDs) were synthesized by the hydrothermal method using citric acid and ethylenediamine. Furthermore, simian virus 40 large T-antigen derived the nuclear targeting sequence (NLS) was bonded on the surface of CDs to obtain CDs-NLS. The antitumor drug doxorubicin was loaded onto the CDs-NLS through an acid-labile hydrazine bond to obtain DOX@CDs. Finally, DOX@CDs were encapsulated in aqueous centers of folate-coated and pH-sensitive liposomes, named pHSL-FA.

resultsIn this paper, a nucleus-targeted nanocomposite (DOX@CDs), which bonds with the nuclear targeting sequence (NLS) and the anticancer drug doxorubicin (DOX), has physicochemical properties of particle size of about 3.8 nm, zeta potential of +31.8 mV and high quantum yield of 64.53%. The negatively charged folate-coated and pH-sensitive liposomes (pHSL-FA) are used as a carrier to reverse the surface charge of DOX@CDs. Compared to free DOX@CDs, pHSL-FA show higher tumor accumulation in 4 T1 tumor-bearing mice and further improve cytotoxicity to tumor cells.

conclusionsThis work proposes a unique nanomedical approach that enables the precise delivery of chemotherapy drugs and significantly reduces side effects, which is promising for clinical translation.

Indexed as

Quantum DotsAnimalsAntibiotics, AntineoplasticApoptosisCarbonDoxorubicinDrug CompoundingFemaleFolic AcidFolic Acid TransportersHep G2 CellsHumansHydrogen-Ion ConcentrationInjections, IntravenousLipidsLiposomesAntibiotics, AntineoplasticCarbonDoxorubicinFolic AcidFolic Acid TransportersLipidsLiposomesbioimagingcarbon dotsdoxorubicinfolateliposomespH-sensitive

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.